CON

SEC source: 0001104659-25-107869 · tm2530505-1_4seq1.xml · nonDerivative · entry 2

Bonner Brigid A. · CIK 0001359852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,496

F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 4, 2026, the first anniversary of the grant date.

SEC source: 0001104659-25-107869 · tm2530505-1_4seq1.xml · nonDerivative · entry 1

Bonner Brigid A. · CIK 0001359852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,748

F1 · kind: Grant of restricted stock which will vest in equal annual installments over five years.

SEC source: 0001415889-25-006577 · form4-03042025_090318.xml · nonDerivative · entry 2

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio

Disclosed balance after: 1,023,455

F2 · kind: The reporting person received 1,023,455 shares of Company's common stock from the Rocco A. Ortenzio Separate Exempt Descendants Trust. The shares are held by the Rocco A. Ortenzio Separate Descendants Trust FBO Robert A. Ortenzio. There was no consideration paid for such distribution.

SEC source: 0001415889-25-006577 · form4-03042025_090318.xml · nonDerivative · entry 1

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Rocco A. Ortenzio Separate Exempt Descendants Trust

Disclosed balance after: 0

F1 · kind: The Rocco A. Ortenzio Separate Exempt Descendants Trust transferred in the aggregate 3,070,367 shares of Company's common stock to the Rocco A. Ortenzio Separate Descendants FBO Robert Ortenzio, the Rocco A. Ortenzio Separate Descendants FBO John Ortenzio and the Rocco A. Ortenzio Separate Descendants FBO Martin Ortenzio. There was no consideration paid for such distribution.

SEC source: 0001415889-24-027932 · form4-11292024_101146.xml · nonDerivative · entry 2

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,526,046

F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 26, 2025, the first anniversary of the grant date

SEC source: 0001415889-24-027932 · form4-11292024_101146.xml · nonDerivative · entry 1

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,519,550

F1 · kind: Grant of restricted stock which will vest in equal annual installments over five years.

SEC source: 0001415889-24-027937 · form4-11292024_101122.xml · nonDerivative · entry 1

Ryan Timothy F. · CIK 0002041273 · See remarks.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027927 · form4-11292024_101124.xml · nonDerivative · entry 1

Anderson John Robert Jr. · CIK 0002031747 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027939 · form4-11292024_101125.xml · nonDerivative · entry 1

Newton William Keith · CIK 0002031707 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,831

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027930 · form4-11292024_101121.xml · nonDerivative · entry 1

deLorimier John A. · CIK 0002030161 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027933 · form4-11292024_101125.xml · nonDerivative · entry 1

Gilbert Greg M. · CIK 0002029837 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027936 · form4-11292024_101151.xml · nonDerivative · entry 2

Watkins Marc R. · CIK 0002029833 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,992

F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 26, 2025, the first anniversary of the grant date.

SEC source: 0001415889-24-027936 · form4-11292024_101151.xml · nonDerivative · entry 1

Watkins Marc R. · CIK 0002029833 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · kind: Grant of restricted stock which will vest in equal annual installments over five years.

SEC source: 0001415889-24-027940 · form4-11292024_101155.xml · nonDerivative · entry 1

Rhine Michael D. · CIK 0002029836 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,098

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027931 · form4-11292024_101104.xml · nonDerivative · entry 1

Devasia Thomas A. · CIK 0002029838 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027926 · form4-11292024_101141.xml · nonDerivative · entry 1

Nelson Su Zan · CIK 0002029842 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027946 · form4-11292024_101145.xml · nonDerivative · entry 1

McAndrew Douglas R. · CIK 0002029844 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027935 · form4-11292024_101115.xml · nonDerivative · entry 1

Kendall Danielle · CIK 0002029835 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027934 · form4-11292024_101133.xml · nonDerivative · entry 1

DiCanio Matthew T. · CIK 0002029693 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027944 · form4-11292024_101141.xml · nonDerivative · entry 1

Kosuth Michael A. · CIK 0002029666 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027929 · form4-11292024_101145.xml · nonDerivative · entry 1

Conser Jonathan P. · CIK 0002029684 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027925 · form4-11292024_101154.xml · nonDerivative · entry 1

Gallara Giovanni · CIK 0002029683 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Grant of restricted stock which will vest in equal annual installments over four years.

SEC source: 0001415889-24-027938 · form4-11292024_101105.xml · nonDerivative · entry 2

Pegus Cheryl · CIK 0001572448 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,992

F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 26, 2025, the first anniversary of the grant date.

SEC source: 0001415889-24-027938 · form4-11292024_101105.xml · nonDerivative · entry 1

Pegus Cheryl · CIK 0001572448 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · kind: Grant of restricted stock which will vest in equal annual installments over five years.

SEC source: 0001415889-24-027928 · form4-11292024_101105.xml · nonDerivative · entry 2

Thomas Daniel · CIK 0001784668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,252

F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 26, 2025, the first anniversary of the grant date.

SEC source: 0001415889-24-027928 · form4-11292024_101105.xml · nonDerivative · entry 1

Thomas Daniel · CIK 0001784668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,796

F1 · kind: Grant of restricted stock which will vest in equal annual installments over five years.

SEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 6

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio

Disclosed balance after: 226,286

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 5

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio

Disclosed balance after: 226,286

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 4

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio

Disclosed balance after: 226,286

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 3

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Rocco A. Ortenzio Separate Exempt Descendants Trust

Disclosed balance after: 3,070,367

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 2

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust

Disclosed balance after: 1,032,115

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 1

ORTENZIO ROBERT A · CIK 0000918697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,513,054

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0001415889-24-027649 · form4-11252024_101128.xml · nonDerivative · entry 1

SELECT MEDICAL CORP · CIK 0001035688 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reporting person distributed these shares to its stockholders on a pro rata basis.

SEC source: 0001415889-24-027650 · form4-11252024_101108.xml · nonDerivative · entry 1

Newton William Keith · CIK 0002031707 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,831

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0001415889-24-027653 · form4-11252024_101128.xml · nonDerivative · entry 1

Rhine Michael D. · CIK 0002029836 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

SEC source: 0001415889-24-027654 · form4-11252024_101127.xml · nonDerivative · entry 1

Thomas Daniel · CIK 0001784668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,260

F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.